
Sign up to save your podcasts
Or
If you take a biologic drug to manage your arthritis, you might be facing some unexpected decisions as more competitors to brand-name biologics — called biosimilars — become available in the U.S. This year, at least eight biosimilars to the self-injectible biologic Humira are coming to market. Learn more about these drugs and what questions to ask your doctor and insurance company.
*Visit the Live Yes! With Arthritis Podcast episode page get show notes, additional resources and read the full transcript: https://www.arthritis.org/liveyes/podcast/new-podcast/ep-75-biosimilars-what-to-expect *
We want to hear from you. Tell us what you think about the Live Yes! With Arthritis Podcast. Get started by emailing [email protected].
Special Guest: Anna Hyde.
4.6
5959 ratings
If you take a biologic drug to manage your arthritis, you might be facing some unexpected decisions as more competitors to brand-name biologics — called biosimilars — become available in the U.S. This year, at least eight biosimilars to the self-injectible biologic Humira are coming to market. Learn more about these drugs and what questions to ask your doctor and insurance company.
*Visit the Live Yes! With Arthritis Podcast episode page get show notes, additional resources and read the full transcript: https://www.arthritis.org/liveyes/podcast/new-podcast/ep-75-biosimilars-what-to-expect *
We want to hear from you. Tell us what you think about the Live Yes! With Arthritis Podcast. Get started by emailing [email protected].
Special Guest: Anna Hyde.
1,719 Listeners
12,946 Listeners
12,624 Listeners
3,471 Listeners
7,537 Listeners
3,375 Listeners
3,531 Listeners
1,841 Listeners
728 Listeners
8,243 Listeners
29,077 Listeners
209 Listeners
41,489 Listeners
1,192 Listeners
19,793 Listeners